Anthem to Cover Exact Sciences' Cologuard under Certain Circumstances | GenomeWeb

NEW YORK (GenomeWeb) – Anthem will cover Exact Sciences' colorectal screening test as a medically necessary procedure under certain conditions, the insurer said in a policy statement on Thursday. 

In its updated policy Anthem said that it will cover the Cologuard test as a medically necessary test once every three years "as a screening technique for individuals in whom colon cancer preventive screening is indicated." For other circumstances, the test is considered investigational and not medically necessary and will not be covered by Anthem.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.